VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution

Stock Information for VolitionRX Limited

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About VolitionRX Limited

Volition Reports Breakthrough in Liquid Biopsy: Achievement of over 99% Purity in Isolating Cancer DNA
Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems
Volition Announces the Appointment of New Distributor for Nu.Q® Discover
VolitionRx Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
Volition Sponsors Symposium at 15th Conference of the European Hidradenitis Suppurativa Foundation
VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q® Cancer Assays
Volition Announces Data to Support Use of Nu.Q® NETs in New Indication
Volition Continues to Extend Access to Nu.Q® Vet Cancer Test

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.